Correction to: Oncogene (2020) 40:322–333 https://doi.org/10.1038/s41388-020-01530-6, Published online: 30 October 2020
The original online version of this article was revised:
The Tubulin loading controls in Supplementary Figure 7 panel A were mistakenly duplicated in panel D.
The Supplementary Figure 7 was corrected. The authors apologize for this oversight.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/s41388-020-01530-6.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Abdullah, A., Akhand, S.S., Paez, J.S.P. et al. Correction: Epigenetic targeting of neuropilin-1 prevents bypass signaling in drug-resistant breast cancer. Oncogene 42, 1418 (2023). https://doi.org/10.1038/s41388-023-02654-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41388-023-02654-1
